MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes
AUTOR(ES)
El-Amraoui, Aziz
FONTE
Oxford University Press
RESUMO
Defects of the myosin VIIa motor protein cause deafness and retinal anomalies in humans and mice. We report on the identification of a novel myosin-VIIa-interacting protein that we have named MyRIP (myosin-VIIa- and Rab-interacting protein), since it also binds to Rab27A in a GTP-dependent manner. In the retinal pigment epithelium cells, MyRIP, myosin VIIa and Rab27A are associated with melanosomes. In transfected PC12 cells, overexpression of MyRIP was shown to interfere with the myosin VIIa tail localization. We propose that a molecular complex composed of Rab27A, MyRIP and myosin VIIa bridges retinal melanosomes to the actin cytoskeleton and thereby mediates the local trafficking of these organelles. The defect of this molecular complex is likely to account for the perinuclear mislocalization of the melanosomes observed in the retinal pigment epithelium cells of myosinVIIa-defective mice.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1084103Documentos Relacionados
- Vezatin, a novel transmembrane protein, bridges myosin VIIA to the cadherin–catenins complex
- Involvement of the Rab27 Binding Protein Slac2c/MyRIP in Insulin Exocytosis
- Arginase: marker, effector, or candidate gene for asthma?
- Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein
- Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes
